We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$60.8B
1-Year Est. Return
42.06%
This Fund
S&P 500
This Quarter
Est. Return
+9.93%
1 Year Est. Return
+42.06%
3 Year Est. Return
+131.09%
5 Year Est. Return
+176.11%
10 Year Est. Return
–
AUM
$49.3B
AUM Growth
+$3.1B
(+6.7%)
Cap. Flow
-$516M
Cap. Flow
% of AUM
-1.05%
Top 10 Holdings %
Top 10 Hldgs %
27.74%
Holding
1,796
New
24
Increased
581
Reduced
361
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$78.5M |
| 2 |
NVIDIA
NVDA
|
+$75.6M |
| 3 |
Eli Lilly
LLY
|
+$70.2M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$58.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$55.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$107M |
| 2 |
Pfizer
PFE
|
+$70M |
| 3 |
Johnson & Johnson
JNJ
|
+$68M |
| 4 |
Danaher
DHR
|
+$56.4M |
| 5 |
Walmart Inc
WMT
|
+$54.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.47% |
| 2 | Healthcare | 17.5% |
| 3 | Financials | 11.6% |
| 4 | Consumer Discretionary | 9.63% |
| 5 | Industrials | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Madrigal Pharmaceuticals
MDGL
$12.5B
| $9.52M | 0.02% |
41,197
+13,421
| +48% | +$3.64M |
|
427
F5
FFIV
$22.1B
| $9.46M | 0.02% |
64,656
+1,245
| +2% | +$177K |
|
428
MSCI
MSCI
$41.7B
| $9.45M | 0.02% |
20,131
+10,416
| +107% | +$5.08M |
|
429
Lamar Advertising Co
LAMR
$15.3B
| $9.36M | 0.02% |
94,276
-31,515
| -25% | -$3.06M |
|
430
Quanta Services
PWR
$93.9B
| $9.35M | 0.02% |
47,615
+3,875
| +9% | +$677K |
|
431
Robert Half
RHI
$4.36B
| $9.34M | 0.02% |
124,179
-68,340
| -35% | -$4.88M |
|
432
Automatic Data Processing
ADP
$110B
| $9.3M | 0.02% |
42,312
+445
| +1% | +$95.9K |
|
433
argenx
ARGX
$64.6B
| $9.25M | 0.02% |
23,743
| – | – |
|
434
Iron Mountain
IRM
$34.8B
| $9.24M | 0.02% |
162,691
+66,790
| +70% | +$3.66M |
|
435
Sun Communities
SUI
$14.5B
| $9.24M | 0.02% |
70,805
+29,275
| +70% | +$3.92M |
|
436
Power Integrations
POWI
$2.82B
| $9.23M | 0.02% |
97,515
+7,275
| +8% | +$607K |
|
437
Leidos
LDOS
$16.7B
| $9.22M | 0.02% |
104,223
+12,080
| +13% | +$1.03M |
|
438
Cleveland-Cliffs
CLF
$7.13B
| $9.19M | 0.02% |
548,200
-5,140
| -0.9% | -$81.5K |
|
439
Omnicom Group
OMC
$22.7B
| $9.13M | 0.02% |
95,968
+3,620
| +4% | +$336K |
|
440
Hewlett Packard
HPE
$69B
| $9.05M | 0.02% |
538,632
-223,410
| -29% | -$3.42M |
|
441
Everest Group
EG
$14.6B
| $9.04M | 0.02% |
26,454
+9,620
| +57% | +$3.47M |
|
442
Neurocrine Biosciences
NBIX
$15.8B
| $9.04M | 0.02% |
95,853
+27,433
| +40% | +$2.68M |
|
443
Generac Holdings
GNRC
$11.1B
| $9.03M | 0.02% |
60,554
+3,403
| +6% | +$388K |
|
444
Alnylam Pharmaceuticals
ALNY
$35.6B
| $8.99M | 0.02% |
47,320
+7,745
| +20% | +$1.54M |
|
445
Nasdaq
NDAQ
$54.2B
| $8.98M | 0.02% |
180,147
+49,950
| +38% | +$2.71M |
|
446
Emerson Electric
EMR
$85.2B
| $8.96M | 0.02% |
99,078
-56,120
| -36% | -$4.72M |
|
447
Gen Digital
GEN
$18.3B
| $8.94M | 0.02% |
481,993
-16,265
| -3% | -$285K |
|
448
Palantir
PLTR
$419B
| $8.91M | 0.02% |
581,170
+401,280
| +223% | +$4.56M |
|
449
CDW
CDW
$19.1B
| $8.88M | 0.02% |
48,379
+1,250
| +3% | +$218K |
|
450
H&R Block
HRB
$6.05B
| $8.84M | 0.02% |
277,335
+128,870
| +87% | +$4.16M |
|
Similar funds
Ensign Peak Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Ensign Peak Advisors held 1,796 positions worth $49.3B, up 6.7% from $46.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q2 2023: portfolio turnover was 3.3%. Ensign Peak Advisors opened 24 new positions and exited 35, leaving the 1,796-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q2 2023 buy was First Horizon: 875,834 shares worth $9.87M.
- Ensign Peak Advisors added most to Microsoft in Q2 2023, an estimated $78.5M increase.
- Ensign Peak Advisors's biggest Q2 2023 reduction was AbbVie, cutting an estimated $107M.
- Ensign Peak Advisors fully exited State Street SPDR S&P 500 ETF Trust in Q2 2023, selling an estimated $45M.
- Ensign Peak Advisors's ten largest holdings make up 28% of its $49.3B portfolio in Q2 2023.
- Ensign Peak Advisors opened 24 new positions and closed 35 in Q2 2023.
- Ensign Peak Advisors's portfolio value rose 6.7% quarter-over-quarter to $49.3B.
Based on Ensign Peak Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.